Who invested in Peptilogics?
Peptilogics's investors include Founders Fund, Innovation Works, Peter Thiel, Presight Capital and AAF Management Ltd., and 2 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$84Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $4.0M sold, first sale Aug 2017
From Peptilogics's own website and the SEC filings it signed: 4 on the team.
On the board, as filediCatherine MottDietrich Stephan
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Peptilogics's investors include Founders Fund, Innovation Works, Peter Thiel, Presight Capital and AAF Management Ltd., and 2 more on record.
Peptilogics has raised $84M across 2 rounds since 2017.
Peptilogics's most recent round was a Series B of $78M in Oct 2025.
Its most recent round, $78M in Oct 2025, is also its largest on record.
Peptilogics's first round on record, in Sept 2017, was backed by Peter Thiel, BlueTree VC and Stefan Roever.
Peptilogics's latest named round is a Series B, in Oct 2025.
Peptilogics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.